BOSTON SCIENTIFIC CORPORATION RESONATE X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
|
Back to Search Results |
|
Model Number G447 |
Device Problems
Over-Sensing (1438); Pacing Problem (1439); Inappropriate/Inadequate Shock/Stimulation (1574); Unexpected Therapeutic Results (1631); Use of Device Problem (1670)
|
Patient Problem
Shock from Patient Lead(s) (3162)
|
Event Date 02/21/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
If pertinent information is provided in the future, a supplemental report will be submitted.
|
|
Event Description
|
It was reported that following the successful implant of this cardiac resynchronization therapy defibrillator (crt-d) system, patient went into supraventricular tachycardia (svt) then atrial fibrillation (af) with rapid ventricular response (rvr) the following day.Over the course of four episodes, there were four bursts of anti-tachycardia pacing (atp) plus a single shock delivered, and the shock converted the patient's rhythm.It was noted that the patient had no prior history of af.Additionally, a stored atrial tachy response (atr) episode from the day after implant showed farfield oversensing.Technical services (ts) reviewed troubleshooting options and programming considerations.This crt-d remains in service.No additional adverse patient effects were reported.
|
|
Event Description
|
It was reported that following the successful implant of this cardiac resynchronization therapy defibrillator (crt-d) system, patient went into supraventricular tachycardia (svt) then atrial fibrillation (af) with rapid ventricular response (rvr) the following day.Over the course of four episodes, there were four bursts of anti-tachycardia pacing (atp) plus a single shock delivered, and the shock converted the patient's rhythm.It was noted that the patient had no prior history of af.Additionally, a stored atrial tachy response (atr) episode from the day after implant showed farfield oversensing.Technical services (ts) reviewed troubleshooting options and programming considerations.This crt-d remains in service.No additional adverse patient effects were reported.Additional information received reported that there was a recommended option for this cardiac resynchronization therapy defibrillator (crt-d) to create a rhythm id template at implant, rather than waiting for the device to create templates every two hours.While it is not certain whether creating this template at implant would have inhibited the previously reported inappropriate tachy therapy, it cannot be ruled out.This crt-d remains in service.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
If pertinent information is provided in the future, a supplemental report will be submitted.
|
|
Search Alerts/Recalls
|
|
|